Adani Portfolio's financial performance remains driven by its core infrastructure businesses, which include utilities, ...

In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon (ICLR – Research Report). The company’s ...

Explore key insights from ICON's Q4 2024 earnings call, including bookings growth, digital innovation, and strategic partnerships driving 2025 growth targets.

UroGen Pharma (NASDAQ:URGN) on Thursday announced the acquisition of oncolytic virus ICVB-1042 and related assets from the ...